178 related articles for article (PubMed ID: 35978522)
1. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.
Abdalkareem Jasim S; Kzar HH; Haider Hamad M; Ahmad I; Al-Gazally ME; Ziyadullaev S; Sivaraman R; Abed Jawad M; Thaeer Hammid A; Oudaha KH; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():109074. PubMed ID: 35978522
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylation site-specific and production-dependent effects of endogenous oxysterols on cholesterol homeostasis: Implications for SREBP-2 and LXR.
Saito H; Tachiura W; Nishimura M; Shimizu M; Sato R; Yamauchi Y
J Biol Chem; 2023 Jan; 299(1):102733. PubMed ID: 36423680
[TBL] [Abstract][Full Text] [Related]
3. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.
Lappano R; Recchia AG; De Francesco EM; Angelone T; Cerra MC; Picard D; Maggiolini M
PLoS One; 2011 Jan; 6(1):e16631. PubMed ID: 21304949
[TBL] [Abstract][Full Text] [Related]
4. Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.
Kosaka S; Miyashita M; McNamala K; Nomura M; Shima H; Kawai M; Sato I; Harada-Shoji N; Ishida T; Choi MH; Sasano H
J Steroid Biochem Mol Biol; 2022 Jul; 221():106103. PubMed ID: 35367370
[TBL] [Abstract][Full Text] [Related]
5. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
Ma L; Cho W; Nelson ER
Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
[TBL] [Abstract][Full Text] [Related]
6. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer.
Munir MT; Ponce C; Powell CA; Tarafdar K; Yanagita T; Choudhury M; Gollahon LS; Rahman SM
J Steroid Biochem Mol Biol; 2018 Oct; 183():1-9. PubMed ID: 29733910
[TBL] [Abstract][Full Text] [Related]
7. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
[TBL] [Abstract][Full Text] [Related]
8. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol and breast cancer pathophysiology.
Nelson ER; Chang CY; McDonnell DP
Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
[TBL] [Abstract][Full Text] [Related]
10. 27-Hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor.
Ayadi S; Friedrichs S; Soulès R; Pucheu L; Lütjohann D; Silvente-Poirot S; Poirot M; de Medina P
J Lipid Res; 2023 Dec; 64(12):100479. PubMed ID: 37981011
[TBL] [Abstract][Full Text] [Related]
11. Re-adopting classical nuclear receptors by cholesterol metabolites.
Umetani M
J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha.
Tian W; Pang W; Ge Y; He X; Wang D; Li X; Hou H; Zhou D; Feng S; Chen Z; Yang Y
J Cell Biochem; 2018 Mar; 119(3):2929-2938. PubMed ID: 29130512
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol hydroperoxides as substrates for cholesterol-metabolizing cytochrome P450 enzymes and alternative sources of 25-hydroxycholesterol and other oxysterols.
van Lier JE; Mast N; Pikuleva IA
Angew Chem Int Ed Engl; 2015 Sep; 54(38):11138-42. PubMed ID: 26230055
[TBL] [Abstract][Full Text] [Related]
14. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of 24(R/S),25-epoxycholesterol and 27-hydroxycholesterol suppresses the proliferation and migration of gastric cancer cells.
Guo F; Hong W; Yang M; Xu D; Bai Q; Li X; Chen Z
Biochem Biophys Res Commun; 2018 Oct; 504(4):892-898. PubMed ID: 30224060
[TBL] [Abstract][Full Text] [Related]
16. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis.
El Roz A; Bard JM; Huvelin JM; Nazih H
Anticancer Res; 2012 Jul; 32(7):3007-13. PubMed ID: 22753765
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol, Oxysterols and LXRs in Breast Cancer Pathophysiology.
Nazih H; Bard JM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079340
[TBL] [Abstract][Full Text] [Related]
18. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
[TBL] [Abstract][Full Text] [Related]
19. Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.
Dalenc F; Iuliano L; Filleron T; Zerbinati C; Voisin M; Arellano C; Chatelut E; Marquet P; Samadi M; Roché H; Poirot M; Silvente-Poirot S
J Steroid Biochem Mol Biol; 2017 May; 169():210-218. PubMed ID: 27343991
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxycholesterol in health and diseases.
Nguyen C; Saint-Pol J; Dib S; Pot C; Gosselet F
J Lipid Res; 2024 Jan; 65(1):100486. PubMed ID: 38104944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
